CPT 81304 MECP2 Deletion/Duplication Reimbursement

CPT code 81304 designates a molecular laboratory procedure that detects long-sequence deletions or duplications in the MECP2 gene, a mutation type associated with neurodevelopmental disorders. Nationally, tests for MECP2 copy number changes are important for diagnostic confirmation, genetic counseling, and care planning for affected patients. Payers apply varied coverage and coding policies for molecular diagnostics, making clear code-level guidance essential for billing and claims adjudication. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what CPT code 81304 represents, typical sites of service, and the clinical context for MECP2 large deletion/duplication testing. The publication summarizes payer coverage patterns, common modifiers and billing considerations, and related service-line implications for laboratories and providers. It also highlights benchmarking notes and policy updates that affect molecular diagnostic claims processing. Data not available in the input is identified where applicable.

Billing Code Overview

CPT code 81304 describes a technical laboratory test to detect genetic changes involving long-sequence deletions or duplications in the MECP2 (methyl CpG binding protein 2) gene. This assay is a molecular genetic test focusing on large-scale copy number variants within the MECP2 gene.

Service type: Molecular pathology / clinical laboratory testing

Typical site of service: Clinical laboratory or reference molecular diagnostic laboratory

Clinical Context

A female pediatric patient, age 2–5 years, presents to a genetics clinic with developmental delay, intellectual disability, delayed speech, loss of acquired language, hand-wringing stereotypies, and hypotonia. The pediatric neurologist orders targeted genetic testing for abnormalities in the MECP2 gene to evaluate for Rett syndrome and related neurodevelopmental disorders. A specimen (peripheral blood) is collected in the outpatient clinic, accompanied by the clinician’s requisition specifying clinical indications and prior testing. The laboratory receives the specimen and performs a technical genetic assay to detect long-sequence deletions or duplications in the MECP2 gene (81304). The testing workflow includes accessioning, DNA extraction, assay setup (e.g., MLPA or comparable copy-number analysis), instrument run, data analysis by laboratory personnel, and generation of a technical report. Results are routed to the ordering clinician, who integrates findings with clinical assessment and counseling. Typical site of service is an outpatient hospital-based genetics clinic or independent clinical molecular diagnostic laboratory with capabilities for molecular cytogenetics and copy-number analysis.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use if billing only the professional interpretation when separate professional reporting is provided by a physician or qualified practitioner.

Taxonomy Code	Specialty	Notes
207RG0100X	Clinical Laboratory Geneticist	Laboratory specialists who perform molecular genetic testing and oversight.
2080P0208X	Clinical Molecular Genetics Laboratory	Clinical laboratory specialty performing molecular diagnostics and copy-number analysis.
2080S0122X	Medical Genetics/Genetics, Medical	Ordering clinicians who interpret results and provide genetic counseling.
2084P0800X	Neurology	Pediatric neurologists who commonly order MECP2 testing for neurodevelopmental disorders.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F84.0`	Autistic disorder	Overlaps with developmental regression and may prompt MECP2 testing in atypical presentations.
`F82`	Specific developmental disorder of motor function	Motor delays and stereotypies may be present in MECP2-related disorders.
`R62.0`	Delayed milestone in childhood	Common presenting problem leading to genetic evaluation including MECP2 copy-number testing.
`R47.81`	Slurred speech (dysarthria)	Speech regression or loss prompts genetic testing for Rett and related conditions.
`G40.909`	Epilepsy, unspecified, not intractable, without status epilepticus	Seizures are frequent in MECP2-related disorders and often trigger genetic testing.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`81225`	Sequencing of the MECP2 gene (e.g., full gene sequencing)	Performed when single-nucleotide variants or small indels are suspected; sequencing often precedes or follows copy-number testing to provide comprehensive MECP2 analysis.
`81226`	Deletion/duplication analysis, MECP2 (alternative assay codes may apply)	Alternative or confirmatory copy-number assay for MECP2 large deletions/duplications; can be used in combination with `81304` depending on methodology.
`88271`	Molecular cytogenetics (e.g., FISH) — targeted probe	Used when a targeted FISH assay is indicated to confirm a specific large deletion detected by copy-number testing.
`88368`	Morphometric analysis and report (if applicable)	Used in some specialized labs for supplemental analysis and reporting of complex results.
`86580`	Specimen handling/collection code (example)	Billed by the collecting facility for specimen procurement and handling prior to molecular testing.

OpenPayer

Summary & Overview

CPT 81304: MECP2 Large Deletion/Duplication Genetic Test